New ultrasound score could spot pregnancy fluid problems earlier
NCT ID NCT07315243
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will enroll 70 pregnant women to test a new way of measuring amniotic fluid using ultrasound. The new method adds the size and shape of the baby's bladder to standard fluid measurements. Researchers hope this combined score will more accurately detect when fluid levels are too low or too high.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a more accurate way to detect abnormal amniotic fluid levels during pregnancy, potentially improving monitoring and outcomes.
- What could go wrong
- This is a small, early-stage study (70 participants) that only compares a new scoring method to existing ultrasound techniques. It may not show a clear benefit or be generalizable to other hospitals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Feb 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Pregnant women aged 18-45 years with singleton pregnancies between 20 and 38 weeks of gestation attending the Obstetrics and Gynecology Department at Assiut University Hospital for routine or indicated ultrasound assessment of amniotic fluid volume.
- Ages
-
18 to 45 years
- Sex
-
Female participants only
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pregnant women aged 18-45 years. * Singleton pregnancy between 20 and 38 weeks of gestation. * Women attending Assiut University Hospital for routine or indicated ultrasound assessment of amniotic fluid volume. * No known major fetal anomalies at the time of inclusion. * Able and willing to provide written informed consent. Exclusion Criteria: * Multiple pregnancy (e.g., twins, triplets). * Pregnancies with known chromosomal or major structural fetal anomalies diagnosed prior to enrollment. * Maternal systemic diseases known to affect amniotic fluid volume (e.g., pregestational or gestational diabetes, chronic hypertension, renal disease). * Contraindications to ultrasound examination. * Inability to provide informed consent or anticipated poor compliance with study procedures.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Amniotic fluid scoring model are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.